Advanced in Anemia

Dr. Hakop Gevorkyan

Internal Medicine
Providence
333 East Magnolia Boulevard, Suite 103, 
Burbank, CA 
Accepting New Patients
Advanced in Anemia
Providence
333 East Magnolia Boulevard, Suite 103, 
Burbank, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Hakop Gevorkyan is a primary care provider, practicing in Internal Medicine in Burbank, California. Dr. Gevorkyan is rated as an Advanced provider by MediFind in the treatment of Anemia. His top areas of expertise are Alveolar Echinococcosis, Echinococcosis, Hydatidosis, and Chronic Obstructive Pulmonary Disease (COPD). Dr. Gevorkyan is currently accepting new patients.

His clinical research consists of co-authoring 10 peer reviewed articles and participating in 13 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Internal Medicine
Licenses
Internal Medicine in CA
Hospital Affiliations
Glendale Adventist Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
LA Care
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

333 East Magnolia Boulevard, Suite 103, Burbank, CA 91502
Call: 818-848-1555

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

13 Clinical Trials

A Phase 1, Open-Label Study to Evaluate the Pharmacokinetics and Tolerability of Cabotegravir and Rilpivirine Long-Acting Injections Following Intramuscular Administration in the Vastus Lateralis Muscle of Healthy Adult Participants
A Phase 1, Open-Label Study to Evaluate the Pharmacokinetics and Tolerability of Cabotegravir and Rilpivirine Long-Acting Injections Following Intramuscular Administration in the Vastus Lateralis Muscle of Healthy Adult Participants
Enrollment Status: Completed
Publish Date: April 22, 2024
Intervention Type: Drug
Study Drugs: Cabotegravir, Rilpivirine
Study Phase: Phase 1
Single-Dose, Dose-Escalation Study With LY3303560 to Evaluate the Safety, Tolerability, and Pharmacokinetics in Healthy Subjects and Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild to Moderate Alzheimer's Disease
Single-Dose, Dose-Escalation Study With LY3303560 to Evaluate the Safety, Tolerability, and Pharmacokinetics in Healthy Subjects and Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild to Moderate Alzheimer's Disease
Enrollment Status: Completed
Publish Date: October 13, 2023
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1 Randomized, Placebo-Controlled Study of LY3316531 in Healthy Subjects and an Open-Label, Single-Dose Study in Patients With Psoriasis
A Phase 1 Randomized, Placebo-Controlled Study of LY3316531 in Healthy Subjects and an Open-Label, Single-Dose Study in Patients With Psoriasis
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1, Two-Part Study of NIP292 Tablets in Healthy Adult Subjects: Part 1 - Randomized, Double-Blind, Placebo-Controlled Assessment of Safety, Tolerability and Pharmacokinetics of Single Ascending Oral Doses; Part 2 - Randomized, Double-Blind, Placebo-Controlled Assessment of Safety, Tolerability and Pharmacokinetics of Multiple Ascending Oral Doses.
A Phase 1, Two-Part Study of NIP292 Tablets in Healthy Adult Subjects: Part 1 - Randomized, Double-Blind, Placebo-Controlled Assessment of Safety, Tolerability and Pharmacokinetics of Single Ascending Oral Doses; Part 2 - Randomized, Double-Blind, Placebo-Controlled Assessment of Safety, Tolerability and Pharmacokinetics of Multiple Ascending Oral Doses.
Enrollment Status: Completed
Publish Date: March 24, 2023
Intervention Type: Drug
Study Drug: NIP292
Study Phase: Phase 1
Phase 1, Multicenter, Randomized, Placebo-Controlled, Triple-Blind, Single-Ascending Dose and Repeat-Dose Trial in Healthy Participants and Participants With Atopic Dermatitis
Phase 1, Multicenter, Randomized, Placebo-Controlled, Triple-Blind, Single-Ascending Dose and Repeat-Dose Trial in Healthy Participants and Participants With Atopic Dermatitis
Enrollment Status: Completed
Publish Date: October 06, 2021
Intervention Type: Drug
Study Drug: LY3454738
Study Phase: Phase 1
Single-Dose and Multiple-Dose, Dose-Escalation Study With LY2599666 to Evaluate the Safety, Pharmacokinetics, and Tolerability in Healthy Subjects and Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild-to-Moderate Alzheimer's Disease
Single-Dose and Multiple-Dose, Dose-Escalation Study With LY2599666 to Evaluate the Safety, Pharmacokinetics, and Tolerability in Healthy Subjects and Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild-to-Moderate Alzheimer's Disease
Enrollment Status: Terminated
Publish Date: June 17, 2020
Intervention Type: Drug
Study Phase: Phase 1
Single-Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3323795 in Healthy Subjects
Single-Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3323795 in Healthy Subjects
Enrollment Status: Completed
Publish Date: April 20, 2020
Intervention Type: Drug
Study Phase: Phase 1
A Phase 2, Double-Blind, Placebo-Controlled, 18-Week Trial of Investigational Dulaglutide Doses Versus Placebo in Patients With Type 2 Diabetes on Metformin Monotherapy
A Phase 2, Double-Blind, Placebo-Controlled, 18-Week Trial of Investigational Dulaglutide Doses Versus Placebo in Patients With Type 2 Diabetes on Metformin Monotherapy
Enrollment Status: Completed
Publish Date: September 23, 2019
Intervention Type: Drug
Study Phase: Phase 2
A Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3361237 in Healthy Subjects
A Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3361237 in Healthy Subjects
Enrollment Status: Completed
Publish Date: September 04, 2019
Intervention Type: Drug
Study Phase: Phase 1
A Multiple-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3041658 in Patients With Skin Diseases
A Multiple-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3041658 in Patients With Skin Diseases
Enrollment Status: Completed
Publish Date: May 03, 2019
Intervention Type: Drug
Study Phase: Phase 1
A Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3375880 in Healthy Subjects
A Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3375880 in Healthy Subjects
Enrollment Status: Completed
Publish Date: December 10, 2018
Intervention Type: Drug
Study Phase: Phase 1
Multiple-Ascending Dose, Safety, Tolerability, and Pharmacokinetic Study of LY3154207 in Healthy Subjects and Subjects With Parkinson's Disease
Multiple-Ascending Dose, Safety, Tolerability, and Pharmacokinetic Study of LY3154207 in Healthy Subjects and Subjects With Parkinson's Disease
Enrollment Status: Completed
Publish Date: March 21, 2017
Intervention Type: Drug
Study Phase: Phase 1
A Single-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3041658 in Healthy Subjects
A Single-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3041658 in Healthy Subjects
Enrollment Status: Completed
Publish Date: February 15, 2017
Intervention Type: Drug
Study Phase: Phase 1
View 12 Less Clinical Trials

10 Total Publications

Pharmacokinetics and tolerability of cabotegravir and rilpivirine long-acting intramuscular injections to the vastus lateralis (lateral thigh) muscles of healthy adult participants.
Pharmacokinetics and tolerability of cabotegravir and rilpivirine long-acting intramuscular injections to the vastus lateralis (lateral thigh) muscles of healthy adult participants.
Journal: Antimicrobial agents and chemotherapy
Published: December 01, 2023
View All 10 Publications
Similar Doctors
Distinguished in Anemia
Dr. Manoj D. Aswani
Internal Medicine
Distinguished in Anemia
Dr. Manoj D. Aswani
Internal Medicine

Arroyo Oaks Medical Associates Inc

2230 Lynn Rd, Suite 200, 
Thousand Oaks, CA 
 (33.0 miles away)
805-495-1066
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Manoj Aswani is a primary care provider, practicing in Internal Medicine in Thousand Oaks, California. Dr. Aswani is rated as a Distinguished provider by MediFind in the treatment of Anemia. His top areas of expertise are High Cholesterol, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, Pacemaker Implantation, and Endoscopy.

Distinguished in Anemia
Dr. Charles K. Kung
Internal Medicine
Distinguished in Anemia
Dr. Charles K. Kung
Internal Medicine

Pih Health Physicians

12675 La Mirada Blvd, Suite 201and401, 
La Mirada, CA 
 (24.8 miles away)
562-903-7339
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Charles Kung is a primary care provider, practicing in Internal Medicine in La Mirada, California. Dr. Kung is rated as an Advanced provider by MediFind in the treatment of Anemia. His top areas of expertise are Anemia, Hemolytic Anemia, Hemolysis, and Congenital Hemolytic Anemia.

Distinguished in Anemia
Dr. Kamran Kalpari
Internal Medicine
Distinguished in Anemia
Dr. Kamran Kalpari
Internal Medicine
8797 Beverly Blvd, Suite 315, 
West Hollywood, CA 
 (8.1 miles away)
310-659-0123
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Kamran Kalpari is a primary care provider, practicing in Internal Medicine in West Hollywood, California. Dr. Kalpari is rated as a Distinguished provider by MediFind in the treatment of Anemia. His top areas of expertise are Long Haul COVID, Glossitis, Pernicious Anemia, Laminectomy, and Endoscopy.

VIEW MORE ANEMIA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Gevorkyan's expertise for a condition
ConditionClose
    • Distinguished
    • Alveolar Echinococcosis
      Dr. Gevorkyan is
      Distinguished
      . Learn about Alveolar Echinococcosis.
      See more Alveolar Echinococcosis experts
    • Advanced
    • Anemia
      Dr. Gevorkyan is
      Advanced
      . Learn about Anemia.
      See more Anemia experts
    • Chronic Obstructive Pulmonary Disease (COPD)
      Dr. Gevorkyan is
      Advanced
      . Learn about Chronic Obstructive Pulmonary Disease (COPD).
      See more Chronic Obstructive Pulmonary Disease (COPD) experts
    • Dementia
      Dr. Gevorkyan is
      Advanced
      . Learn about Dementia.
      See more Dementia experts
    • Echinococcosis
      Dr. Gevorkyan is
      Advanced
      . Learn about Echinococcosis.
      See more Echinococcosis experts
    • End-Stage Renal Disease (ESRD)
      Dr. Gevorkyan is
      Advanced
      . Learn about End-Stage Renal Disease (ESRD).
      See more End-Stage Renal Disease (ESRD) experts
    • Familial Hypertension
      Dr. Gevorkyan is
      Advanced
      . Learn about Familial Hypertension.
      See more Familial Hypertension experts
    View All 12 Advanced Conditions
    • Experienced
    • Acute Erythroid Leukemia (AEL)
      Dr. Gevorkyan is
      Experienced
      . Learn about Acute Erythroid Leukemia (AEL).
      See more Acute Erythroid Leukemia (AEL) experts
    • Acute Kidney Failure
      Dr. Gevorkyan is
      Experienced
      . Learn about Acute Kidney Failure.
      See more Acute Kidney Failure experts
    • Alzheimer's Disease
      Dr. Gevorkyan is
      Experienced
      . Learn about Alzheimer's Disease.
      See more Alzheimer's Disease experts
    • Atherosclerosis
      Dr. Gevorkyan is
      Experienced
      . Learn about Atherosclerosis.
      See more Atherosclerosis experts
    • Blood Clots
      Dr. Gevorkyan is
      Experienced
      . Learn about Blood Clots.
      See more Blood Clots experts
    • Cellulitis
      Dr. Gevorkyan is
      Experienced
      . Learn about Cellulitis.
      See more Cellulitis experts
    View All 59 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.